E-drug: Asia Course on Promoting Rational Drug Use
-------------------------------------------------------------------------
International Network for Rational Use of Drugs, Management Sciences for
Health, Arlington, USA,
Essential Drugs and Medicines Policy, World Health Organization, Geneva,
and
INRUD Indonesia
Announce a training course
PROMOTING RATIONAL DRUG USE
9-21 October 2000, Padang, West Sumatera, Indonesia
A two-week course for physicians, pharmacists, health programme managers,
officials from ministries of health, universities and private
organizations, and other interested organizations in improving the use of
drugs.
Trainers: Dr. Edelisa Carandang, Dr. Johana E.P. Hadiyono, Dr. Kathy
Holloway, Dr. Richard Laing, Dr. David Lee, Dr. Dennis Ross-Degnan, Dr.
Budiono Santoso, Dr. Sri Suryawati
COURSE OBJECTIVES
The course will focus on methods of studying and remedying inappropriate
drug use, including problems with ways in which drugs are prescribed,
dispensed and consumed. Participants will learn practical approaches for
applying key concepts such as essential drug lists, indicators of drug use,
and methods for changing inappropriate drug use behaviour.
COURSE DESIGN
The course will be conducted in English and will consist of presentations,
discussions, group activities, and field-work. This course is highly
participatory, and the exchange of skills and experience among participants
adds depth to the learning process. Course materials are based on those
developed by Management Sciences for Health, the Harvard Drug Policy Group,
World Health Organization (WHO), and International Network for Rational Use
of Drugs (INRUD) country core groups. Experiences gained in the field by
participating countries and studies presented at the 1st International
Conference on Improving Use of Medicines, Chiang Mai, Thailand, 1997, will
be examined. The participants will be exposed to a wide range of
international experiences and materials.
COURSE HIGHLIGHTS
- Identification of drug use problems
- Factors that influence prescribing patterns
- Indicators for assessing drug use
- Methods to evaluate effectiveness of drug use interventions
- Field exercises to assess drug use
- Standard treatment for improving quality of care
- Influencing prescribing patterns
- Changing prescriber training
- Public education about drug use
- Planning intervention studies
COURSE FEE AND APPLICATION
The fee of US$2,500 covers tuition, course materials, shared accommodation
in a four-star hotel. Those unwilling to share accommodation must be
prepared to pay extra for single rooms (rates available upon request).
Tuition will also cover breakfast and lunch. Participants will be provided
US$ 20 perday to cover expenses for regular dinners that will not be
provided by the organizer. Participants should plan to bring sufficient
money for incidental expenses like laundry, postage, telephone calls,
souvenirs, airport tax, etc. Airfare and health insurance are the
responsibility of the sponsoring organization. Participants should also
expect to receive 12 kg of training materials. Course location and lodging
will be at the Hotel Bumiminang, Jl. Bundo Kandung 20-28, Padang, West
Sumatera. Applications and fees are due no later than September 30, 2000.
Please send requests for further information and applications to:
Dr. Sri Suryawati, INRUD Indonesia
Department of Clinical Pharmacology
Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia 55281
Fax: 62 - 274 - 563596 and 543711
E-mail suryawati@yogya.wasantara.net.id
COLLABORATING INSTITUTION
The International Network for Rational Use of Drugs (INRUD) Secretariat is
located at Management Sciences for Health (MSH), in Arlington, Virginia.
In 1989, MSH collaborated with the Drug Policy Group at Harvard Medical
School, the World Health Organization, the Karolinska Institute, and senior
health professionals in Africa and Asia to form INRUD. INRUD core groups
have been established in Bangladesh, Ghana, Indonesia, Nigeria, Nepal,
Philippines, Tanzania, Thailand, Uganda and Zimbabwe. The Harvard Drug
Policy Group assists in carrying out scientific and technical functions of
the INRUD Secretariat. The MSH Drug Management Program, formed in 1981,
works to improve the availability, affordability, quality, and appropriate
use of essential drugs through technical assistance in planning,
implementing, and evaluating pharmaceutical management programmes. It has
conducted over 20 courses and workshops involving nearly 500 participants
in Boston and developing countries worldwide. Topics include national drug
policy, selection, procurement, distribution, financial management, and use
of pharmaceuticals, as well as training in computer applications for drug
supply management.
WHO Essential Drug and Medicines Policy (EDM) was formerly the WHO Action
Programme on Essential Drugs. WHO EDM provides operational support to
countries in developing national drug policies, emphasizing the concept of
essential drugs and rational drug use. The department assists in building
leadership, promoting advocacy and mobilizing global collaboration to
improve the world drug situation. WHO EDM works on four important
principles: (1) to respond to the needs of member states; (2) to strengthen
national capacity through improved infrastructure and training; (3) to
promote decentralized decision making and operational responsibility; (4)
to integrate the essential drugs programmes into the overall health care
system. WHO EDM also undertakes a comprehensive range of research and
development activities aimed at solving problems in procurement, equal
accessibility, and appropriate use of safe and effective pharmaceuticals.
It publishes many relevant materials, including the Essential Drugs
Monitor.
INRUD-Indonesia has been an active country member of the International
Network for Rational Use of Drugs since the inauguration of the Network in
1990. INRUD Indonesia has contributed significantly in developing
innovative strategies to improve drug use problem in primary healthcare
setting, hospital setting, as well as in the community setting. Among
others are, Interactive Group Discussion to reduce injection use in health
facilities, self-monitoring to improve drug use problems at district level,
indicator-based monitoring strategy to improve drug use in hospitals, and
CBIA, a public educational module to improve the quality of
self-medication.
TRAINERS
Dr. Edelisa Carandang is a medical officer at the Department of Essential
Drugs and Medicines Policy, WHO. She has a vast experience in the
development of national drug policies and strategies to improve rational
use of drugs. She was formerly responsible for rational drug use activities
under the Phillipine National Drug Policy, Department of Health, and later
appointed Officer-in-Charge of the programme.
Dr. Kathy Holloway is a medical officer with the department of Essential
Drugs and Medicines Policy in WHO Geneva. She worked for 10 years as a
clinician in the UK national health service, and then 10 years, in both
clinical medicine and public health, in Asia. Her experience in Asia
includes managing a small hospital where malaria was the most prevalent
disease, TB and leprosy control, and essential drugs. During 1991-8, whilst
in Nepal managing an essential drugs programme which included revolving
drug funds, she conducted research into the effect of different kinds of
user fee on the rational use of drugs.
Dr. Richard Laing is Associate Professor of International Health at Boston
University School of Public HealthHe previously worked at Management
Sciences for Health where he coordinated the INRUD Network and taught PRDU
Course frequently. He is now involved in putting the course on the World
Wide Web and CD-Rom in a WHO supported project.
Dr. David Lee is Deputy Director and Drug Information Coordinator for the
Drug Management Program at MSH, and is the INRUD Coordinator. From 1983
through 1993, he worked for the Panama Social Security Medicines
Commission. During this period, Dr. Lee also collaborated extensively with
the Pan American Health Organization in formulary development, drug
utilization research, and drug information workshops in many Latin American
countries.
Dr. Johana E.P. Hadiyono is currently chair of the Department of Clinical
Psychology, Faculty of Psychology, Gadjah Mada University. As a behavioral
scientist she brought a new sight to INRUD by modifying and applying
behavioral assessment and intervention to drug use studies.
Dr. Dennis Ross-Degnan is Assistant Professor of the Drug Policy Group at
Harvard Medical School. He has published widely on pharmaceutical topics
including innovative experiments to improve drug use and evaluations of
pharmaceutical policies in the USA and in developing countries. He
developed the Promoting Rational Drug Use Course with colleagues at Harvard
and Management Sciences for Health (MSH)
Dr. Budiono Santoso is a clinical pharmacologist. He is currently the
Regional Adviser on Essential Drugs at the WHO - Western Pacific Regional
Office in Manila. Before joining the WHO-WPRO, he was the Chairman of
Clinical Pharmacology, and the Director of Center for Clinical Pharmacology
& Drug Policy of Gadjah Mada University, which has been assigned as the WHO
Collaborating Center for Research and Training on Rational Use of Drugs.
For the last 15 years he has worked in many developing countries serving as
consultant for the essential drug programme and rational use of drugs. He
is also Sub-committee Chairman on Clinical Pharmacology for Developing
Countries of the Division of Clinical Pharmacology of the International
Union of Pharmacology (IUPHAR).
Dr. Sri Suryawati is a pharmacist with extensive experience in public
health pharmacy, rational drug use, pharmaceutical management and policy,
and clinical pharmacokinetics. She is currently the Head of Clinical
Pharmacology Department, Facultty of Medicine, Gadjah Mada University. She
is also the Coordinator of INRUD-Indonesia, acted as consultant in drug
evaluation to the Ministry of Health since 1987.
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.